Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Mitochondrial disease

Gene: MT-TQ

Amber List (moderate evidence)

MT-TQ (mitochondrially encoded tRNA glutamine)
EnsemblGeneIds (GRCh38): ENSG00000210107
EnsemblGeneIds (GRCh37): ENSG00000210107
OMIM: 590030, Gene2Phenotype
MT-TQ is in 2 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

I don't know

LIMITED by ClinGen.

Three unique variants (m.4332G>A, m.4369_4370insA, m.4381A>G) reported in three probands across 3 publications. Single fiber testing further supported the pathogenicity of several of these variants. Age of onset in affected individuals was five years old, teens, and 20 years old. Clinical features in affected individuals included stroke-like episodes, hearing loss, myopathy, and Leber Hereditary Optic Neuropathy (LHON). Brain imaging was variable. Muscle biopsies showed ragged red fibers and COX-negative fibers. Metabolic screening investigations were only reported in one individual and showed high cerebrospinal fluid (CSF) lactate with normal blood lactate. Heteroplasmy levels in affected individuals were highest in muscle when multiple tissues were assessed (61-87% in muscle).
Created: 29 Sep 2025, 5:45 p.m. | Last Modified: 29 Sep 2025, 5:45 p.m.
Panel Version: 0.1060
Sources: Expert list
Created: 19 Apr 2020, 2:06 p.m.

Mode of inheritance
MITOCHONDRIAL

Phenotypes
Mitochondrial disease (MONDO:0044970), MT-TQ-related

Publications

Details

Mode of Inheritance
MITOCHONDRIAL
Sources
  • Expert Review Amber
  • Expert list
Phenotypes
  • Mitochondrial disease (MONDO:0044970), MT-TQ-related
Tags
mtDNA
OMIM
590030
Clinvar variants
Variants in MT-TQ
Penetrance
None
Publications
Panels with this gene

History Filter Activity

29 Sep 2025, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: MT-TQ were changed from MELAS; deafness; mitochondrial myopathy to Mitochondrial disease (MONDO:0044970), MT-TQ-related

29 Sep 2025, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: MT-TQ were set to

29 Sep 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: mt-tq has been classified as Amber List (Moderate Evidence).

19 Apr 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: mt-tq has been classified as Green List (High Evidence).

19 Apr 2020, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag mtDNA tag was added to gene: MT-TQ.

19 Apr 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: mt-tq has been classified as Green List (High Evidence).

19 Apr 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: MT-TQ was added gene: MT-TQ was added to Mitochondrial disease. Sources: Expert list Mode of inheritance for gene gene: MT-TQ was set to MITOCHONDRIAL Phenotypes for gene: MT-TQ were set to MELAS; deafness; mitochondrial myopathy Review for gene: MT-TQ was set to GREEN